Observational cohort study reveals adverse outcomes linked to donor bloodstream infections in organ recipients, suggesting intervention needs.
In our cohort, 14% of recipients received organs from donors with BSI but only five CRE DDIs were observed. Receiving organs from donors with unrecognized MDR BSI may adversely affect recipient outcomes; further studies are needed to determine whether newer antimicrobial agents can mitigate this risk.
No takes yet. Share an insight, caveat, or question.
Cona et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: